These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31839704)
1. An Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic Rats. Ahmed TA; Mussari MA; Abdel-Hady SE; El-Say KM Drug Des Devel Ther; 2019; 13():4035-4051. PubMed ID: 31839704 [TBL] [Abstract][Full Text] [Related]
2. Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation. Ahmed TA; Alharby YA; El-Helw AR; Hosny KM; El-Say KM Drug Des Devel Ther; 2016; 10():405-15. PubMed ID: 26855565 [TBL] [Abstract][Full Text] [Related]
3. Co-Delivery of Atorvastatin Nanocrystals in PLGA based in situ Gel for Anti-Hyperlipidemic Efficacy. Kurakula M; Ahmed TA Curr Drug Deliv; 2016; 13(2):211-20. PubMed ID: 26549039 [TBL] [Abstract][Full Text] [Related]
4. Attenuation of lipid levels in triton induced hyperlipidemia rats through rosuvastatin calcium nanoparticles: Pharmacokinetic and pharmacodynamic studies. Dudhipala NR; Ettireddy SR; Puchakayala GR Chem Phys Lipids; 2021 Jul; 237():105081. PubMed ID: 33811848 [TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. He W; Guo X; Feng M; Mao N Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520 [TBL] [Abstract][Full Text] [Related]
7. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole. Ahmed TA; Aljaeid BM Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311 [TBL] [Abstract][Full Text] [Related]
8. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. Rizwanullah M; Amin S; Ahmad J J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665 [TBL] [Abstract][Full Text] [Related]
9. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562 [No Abstract] [Full Text] [Related]
10. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability. Patel N; Nakrani H; Raval M; Sheth N Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408 [TBL] [Abstract][Full Text] [Related]
11. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472 [TBL] [Abstract][Full Text] [Related]
12. Formulation by design approach for development of ultrafine self-nanoemulsifying systems of rosuvastatin calcium containing long-chain lipophiles for hyperlipidemia management. Beg S; Katare OP; Singh B Colloids Surf B Biointerfaces; 2017 Nov; 159():869-879. PubMed ID: 28892871 [TBL] [Abstract][Full Text] [Related]
13. A PLGA-reinforced PEG in situ gel formulation for improved sustainability of hypoglycaemic activity of glimepiride in streptozotocin-induced diabetic rats. Ahmed OAA; El-Say KM; Alahdal AM Sci Rep; 2017 Nov; 7(1):16384. PubMed ID: 29180715 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacokinetics of celecoxib loaded endcapped PCLA-PEG-PCLA thermogels in rats after subcutaneous administration. van Midwoud PM; Sandker M; Hennink WE; de Leede LGJ; Chan A; Weinans H Eur J Pharm Biopharm; 2018 Oct; 131():170-177. PubMed ID: 30075312 [TBL] [Abstract][Full Text] [Related]
16. Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis. Hosny KM; Rizg WY PLoS One; 2018; 13(6):e0197540. PubMed ID: 29856752 [TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid. Jhawat V; Gupta S; Saini V Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800 [TBL] [Abstract][Full Text] [Related]
20. Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery. Suares D; Prabhakar B Drug Dev Ind Pharm; 2017 Feb; 43(2):213-224. PubMed ID: 27593545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]